Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma
Science Advances · 2026
DOI: 10.1126/sciadv.adu0031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Dennis Wylie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Molecular Biosciences and Medicine / Oncology, University of Texas at Austin, Austin, TX 78712, USA. Hauptthemen laut MEDLINE: Introns, RNA Splicing, Inflammatory Breast Neoplasms, Leukocytes, Mononuclear. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Welch Foundation.
Abstract (Originalsprache)
Inflammatory breast cancer (IBC), an aggressive and lethal breast cancer subtype, lacks unequivocal genomic differences or robust biomarkers that differentiate it from non-IBC. Here, TGIRT-seq revealed myriad differences in tumors, PBMC, and plasma RNAs that distinguished IBC patients from non-IBC patients and healthy donors across different tested breast cancer subtypes. By mapping reads to genome and transcriptome reference sequences and quantitating intron-to-exon read depth ratios (IDRs), we developed methods for parallel analysis of transcriptional and posttranscriptional gene regulation. This analysis identified numerous protein-coding genes in IBC patient tumors and PBMCs with high IDRs, suggesting rate-limiting RNA splicing that decreases mRNA production. Mirroring gene expression differences in tumors and PBMCs, overrepresented protein-coding gene RNAs in IBC patient plasma were largely intron RNA fragments, while those in non-IBC patient and healthy donor plasma were largely mRNA fragments. Our findings provide insights into IBC and should enable monitoring disease progression by liquid biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Molecular Biosciences and Medicine / Oncology, University of Texas at Austin, Austin, TX 78712, USA.
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Dennis Wylie, Xiaoping Wang, Jun Yao, Hengyi Xu, Elizabeth A Ferrick-Kiddie, Toshiaki Iwase, Naoto T Ueno, Alan M Lambowitz
Förderung
- NCI NIH HHS
- National Institutes of Health
- Welch Foundation
- Breast Cancer Research Foundation
- Morgan Welch Inflammatory Breast Cancer Research Program
- State of Texas Rare and Aggressive Breast Cancer Research Program Grant
Zitieren
APA
Wylie, D., Wang, X., Yao, J., Xu, H., Ferrick-Kiddie, E. A., Iwase, T., Krishnamurthy, S., Ueno, N. T., & Lambowitz, A. M. (2026). Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma. Science Advances. https://doi.org/10.1126/sciadv.adu0031
Vancouver
Wylie D, Wang X, Yao J, Xu H, Ferrick-Kiddie EA, Iwase T, et al. Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma. Science Advances. 2026. doi:10.1126/sciadv.adu0031
BibTeX
@article{Wylie2026,
author = {Wylie, Dennis and Wang, Xiaoping and Yao, Jun and Xu, Hengyi and Ferrick-Kiddie, Elizabeth A and Iwase, Toshiaki and Krishnamurthy, Savitri and Ueno, Naoto T and Lambowitz, Alan M},
title = {Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adu0031}
}
EUVIMED